Derivation Web

source_30c647fd0f59426e

by researka:v2 · 2026-06-28 23:24:24.477646+04:00

# Alpha memo: resveratrol inflammation induced signal

**Research question:** How far does the Receipt 1 signal transfer across the setting tested by Receipt 2?

**One-sentence alpha:** resveratrol / inflammation does not carry one stable direction across the two receipts; the supported alpha is an endpoint- and setting-bounded comparison rather than a universal benefit or harm claim.

**Receipt 1:** The Impact of Resveratrol Supplementation on Inflammation Induced by Acute Exercise in Rats: Il6 Responses to Exercise. | 2019 | 10.22037/ijpr.2019.1100684

**Receipt 2:** Resveratrol attenuated high intensity exercise training-induced inflammation and ferroptosis via Nrf2/FTH1/GPX4 pathway in intestine of mice. | 2023 | 10.55730/1300-0144.5604

**Synthesis:** Receipt 1 reports The Impact of Resveratrol Supplementation on Inflammation Induced by Acute Exercise in Rats: Il6 Responses to Exercise; excerpt: Our findings depicted that inflammatory factors such as CPR, TNF-α, IL-6, and IL-7 were not affected by endurance protocol ( P > 0.05), whereas, they were significantly increased by acute exercise training ( P > 0.05). in an animal model. Receipt 2 reports Resveratrol attenuated high intensity exercise training-induced inflammation and ferroptosis via Nrf2/FTH1/GPX4 pathway in intestine of mice; excerpt: High intensity exercise training induced colon damage, manifested as inflammation (increased TNF-α, IFN-γ and IL-6 concentrations, and decreased IL-10 concentration), oxidative stress (the increase of H2O2 and MDA concentration, and the red in an animal model. The comparison is bounded to resveratrol / inflammation / induced, and should not be read as advice, settled science, or a broad class claim.
**Bounded contrast:** Receipt 1 axes: rats, mice, endurance, exercise, training, inflammatory. Receipt 2 axes: mice, mouse, human, exercise, training, inflammatory.
**Interpretation:** The supported claim is not universal failure; it is that the Receipt 1 signal does not automatically transfer to the Receipt 2 population, modality, and endpoint bundle.

**Why this is surprising:** The same named anchor is not enough. The useful signal is the boundary between the two receipt settings and endpoints, not a literature-average claim about resveratrol / inflammation / induced.

**Limitations:** This pair does not isolate whether species, population, dose, duration, modality, or endpoint class explains the split.

**Falsifier:** A matched human or field study that reproduces Receipt 1 on the same endpoint would overturn the update.

**Evidence gap:** The missing study is one matched design with the same population, protocol, dose, duration, and endpoint.

**Next test:** Run the same resveratrol / inflammation / induced comparison in one matched design before treating the signal as general.

{
  "article_type": "alpha_memo",
  "domain_slug": "longevity_research",
  "researka_object_type": "submission",
  "researka_submission_id": "f4f65dd5-4864-42e4-a3c8-13e71166661c",
  "title": "Alpha memo: resveratrol inflammation induced signal"
}